ARCO INTERPHARMA AS

3031 DRAMMEN

Finances

Return on Equity

−26,68 %

Current Ratio

11,68

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	897 000	870 000	1 317 000	1 153 000
Net Income	−333 000	−260 000	−498 000	−307 000
Total Assets	1 365 000	1 653 000	2 002 000	2 504 000
Total Equity	1 248 000	1 582 000	1 842 000	2 340 000

Income (NOK)	2022	2021	2020	2019
Revenue	897 000	870 000	1 317 000	1 153 000
Expenditure	1 228 000	1 130 000	1 815 000	1 459 000
Operating Profit	−332 000	−260 000	−498 000	−306 000
Financial Income	0	0	0	1 000
Financial Costs	2 000	0	0	2 000
Financial Balance	−2 000	0	0	−1 000
Earnings Before Tax	−333 000	−260 000	−498 000	−307 000
Tax	0	0	0	0
Net Income	−333 000	−260 000	−498 000	−307 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	22 000	34 000	0	0
Total Current Assets	1 343 000	1 619 000	2 002 000	2 504 000
Total Assets	1 365 000	1 653 000	2 002 000	2 504 000
Total Retained Equity	1 148 000	1 482 000	1 742 000	2 240 000
Total Equity	1 248 000	1 582 000	1 842 000	2 340 000
Total Long-Term Debt	2 000	0	0	0
Total Current Debt	115 000	72 000	160 000	165 000
Total Equity and Debt	1 365 000	1 653 000	2 002 000	2 504 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	897 000	870 000	1 317 000	1 153 000
Other Income	0	0	0	0
Revenue	897 000	870 000	1 317 000	1 153 000
Cost of Goods Sold	440 000	498 000	644 000	303 000
Salary Costs	576 000	378 000	874 000	924 000
Depreciation	12 000	2 000	0	0
Impairment	0	0	0	0
Expenditure	1 228 000	1 130 000	1 815 000	1 459 000
Operating Profit	−332 000	−260 000	−498 000	−306 000
Financial Income	0	0	0	1 000
Financial Costs	2 000	0	0	2 000
Financial Balance	−2 000	0	0	−1 000
Dividends	0	0	0	0
Net Income	−333 000	−260 000	−498 000	−307 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	22 000	34 000	0	0
Total Tangible Assets	22 000	34 000	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	22 000	34 000	0	0
Stock	411 000	848 000	658 000	540 000
Total Investments	128 000	128 000	0	0
Cash, Bank	590 000	424 000	1 116 000	1 750 000
Total Current Assets	1 343 000	1 619 000	2 002 000	2 504 000
Total Assets	1 365 000	1 653 000	2 002 000	2 504 000
Total Equity	1 248 000	1 582 000	1 842 000	2 340 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	2 000	0	0	0
Creditors	8 000	5 000	2 000	−536 000
Unpaid Taxes	59 000	36 000	88 000	86 000
Dividends	0	0	0	0
Other Current Debt	47 000	31 000	71 000	614 000
Total Current Debt	115 000	72 000	160 000	165 000
Total Equity and Debt	1 365 000	1 653 000	2 002 000	2 504 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−26,68 %	−16,43 %	−27,04 %	−13,12 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	−37,01 %	−29,89 %	−37,81 %	−26,54 %
Current Ratio	11,68	22,49	12,51	15,18
Quick Ratio	−4,54	−2,09	−4,02	−6,68
Equity Ratio	0,91	0,96	0,92	0,93
Gross Profit Margin	50,95 %	42,76 %	51,1 %	73,72 %